ryaltris 25 mikrogram/dos + 600 mikrogram/dos nässpray, suspension
glenmark pharmaceuticals s.r.o. - mometasonfuroatmonohydrat; olopatadinhydroklorid - nässpray, suspension - 25 mikrogram/dos + 600 mikrogram/dos - mometasonfuroatmonohydrat 25,86 mikrog aktiv substans; etanol, vattenfri hjälpämne; olopatadinhydroklorid 665 mikrog aktiv substans; bensalkoniumklorid hjälpämne
zalerg 0,25 mg/ml ögondroppar, lösning
laboratoires thea - ketotifenvätefumarat - Ögondroppar, lösning - 0,25 mg/ml - glycerol hjälpämne; ketotifenvätefumarat 0,345 mg aktiv substans - ketotifen
profinil 100 mg tablett
2care4 aps - modafinil - tablett - 100 mg - laktosmonohydrat hjälpämne; modafinil 100 mg aktiv substans
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningit, meningokock - vacciner - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
naltrexone accord 50 mg filmdragerad tablett
accord healthcare b.v. - naltrexonhydroklorid - filmdragerad tablett - 50 mg - laktosmonohydrat hjälpämne; naltrexonhydroklorid 50 mg aktiv substans